Syt13 gene therapy extended the survival of ALS (SOD1G93A) and SMA (SMAΔ7) mice by preserving motor neuron somas, axons, and the innervation of muscle endplates. The gene discussed is SYT13; the disease is amyotrophic lateral sclerosis.